Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma

Toni K. Choueiri

Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA

Robert J. Motzer

Memorial Sloan Kettering Cancer Center, New York

Jose A. Karam

University of Texas M.D. Anderson Cancer Center, Houston

Wesley Yip

Division of Urology and Urologic Oncology Department of Surgery City of Hope Comprehensive Cancer Center Duarte California USA

Cristina Suarez

Department of Medical Oncology Vall d'Hebron Institute of Oncology Hospital Universitari Vall d'Hebron Barcelona Spain

Dingwei Ye

Fudan University Shanghai Cancer Center, Shanghai

Zhisong He

Christian Caglevic

Centro de Investigacion e Innovación en Cáncer Fundación Arturo López Pérez, Santiago, Chile

Tom Ferguson

Fiona Stanley Hospital, Perth, WA, Australia

Yen-Hwa Chang

Taipei Veterans General Hospital, Taipei, Taiwan

Carlos Rojas

Bradford Hill Investigación Clínica, Santiago, Chile

Roberto Iacovelli

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome

Yüksel Ürün

Ankara University Medical Faculty, Ankara, Turkey

Elena Verzoni

Genitourinary Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

Juan Carlos Vázquez Limón

Servicio de Oncología, Hospital Civil de Guadalajara Fray Antonio Alcalde, Universidad de Guadalajara, Jalisco, México

Camillo Porta

Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari, Bari, Italy

Robert G. Uzzo

Fox Chase Cancer Center–Temple Health, Philadelphia

Jae Lyun Lee

Balaji Venugopal

Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

Rana R. McKay

Department of Medicine, Urology, and Radiation Medicine and Applied Sciences University of California‐San Diego La Jolla California USA

Hans Hammers

Division of Hematology‐Oncology, Department of Internal Medicine University of Texas Southwestern Medical Center Dallas Texas USA

Hideaki Miyake

Hamamatsu University School of Medicine, Hamamatsu, Japan

Jad Chahoud

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Hong Liu

Joseph E. Burgents

Merck, Rahway, NJ

Manish Sharma

Professor and Head, Department of Oral and Maxillofacial Pathology, Jawahar Medical Foundation’s Annasaheb Chudaman Patil Memorial Dental College, Dhule, Maharashtra, India

Thomas B. Powles

Barts Health NHS Trust, Barts Cancer Institute, Queen Mary University of London, London